Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial protocol comparing progestin-primed ovarian stimulation (PPOS) starting at stimulation with a GnRH antagonist protocol for ovarian stim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH antagonist
  • Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

Sponsor: Ginefiv | Conditions: Stimulation in the Ovary, Embryo | Phase 4 | Status: NOT_YET_RECRUITING